Variable | Category | Number (%) |
---|---|---|
N = 664 | ||
Sex | Female | 311 (46.8) |
Male | 353 (53.2) | |
Age | Less than 75 years | 496 (74.7) |
75 years or older | 168 (25.3) | |
Chemotherapy | CHOP | 334 (50.3) |
PMitCEBO | 330 (49.7) | |
GCSF | No | 330 (49.7) |
Yes | 334 (50.3) | |
Stage | I | 70 (10.5) |
II | 176 (26.5) | |
III | 193 (29.1) | |
IV | 225 (33.9) | |
B symptoms | No | 311 (46.8) |
Yes | 353 (53.2) | |
ECOG Performance status | 0 | 206 (31.0) |
1 | 264 (39.8) | |
2 | 131 (19.7) | |
3 | 39 (5.9) | |
4 | 13 (2.0) | |
No data | 11 (1.7) | |
Plasma LDH concentration (mU/L) | ||
Normal (0.2–0.5) | 216 (32.5) | |
Elevated (> 0.5) | 381 (57.4) | |
No data | 67 (10.1) | |
Bone marrow aspirate | Not involved | 508 (76.5) |
Involved | 57 (8.6) | |
No data | 99 (14.9) | |
Bone marrow trephine | Not involved | 487 (73.3) |
Involved | 89 (13.4) | |
No data | 88 (13.3) |